[{"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions", "3 Months Ended"], ["Dec. 25, 2021", "Dec. 26, 2020"]], "sections": ["Operating expenses:", "Earnings Per Share [Abstract]", "Shares used in computing earnings per share:"], "data": [["Net sales", "$ 123,945", "$ 111,439"], ["Cost of sales", "69,702", "67,111"], ["Gross margin", "54,243", "44,328"], ["Research and development", "6,306", "5,163"], ["Selling, general and administrative", "6,449", "5,631"], ["Total operating expenses", "12,755", "10,794"], ["Operating income", "41,488", "33,534"], ["Other income/(expense), net", "(247)", "45"], ["Income before provision for income taxes", "41,241", "33,579"], ["Provision for income taxes", "6,611", "4,824"], ["Net income", "$ 34,630", "$ 28,755"], ["Basic (in dollars per share)", "$ 2.11", "$ 1.70"], ["Diluted (in dollars per share)", "$ 2.10", "$ 1.68"], ["Basic (in shares)", "16,391,724", "16,935,119"], ["Diluted (in shares)", "16,519,291", "17,113,688"], ["Products", "", ""], ["Net sales", "$ 104,429", "$ 95,678"], ["Cost of sales", "64,309", "62,130"], ["Services", "", ""], ["Net sales", "19,516", "15,761"], ["Cost of sales", "$ 5,393", "$ 4,981"]]}, {"headers": [["CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions", "Dec. 25, 2021", "Sep. 25, 2021"]], "sections": ["Current assets:", "Non-current assets:", "Current liabilities:", "Non-current liabilities:", "Shareholders\u2019 equity:"], "data": [["Cash and cash equivalents", "$ 37,119", "$ 34,940"], ["Marketable securities", "26,794", "27,699"], ["Accounts receivable, net", "30,213", "26,278"], ["Inventories", "5,876", "6,580"], ["Vendor non-trade receivables", "35,040", "25,228"], ["Other current assets", "18,112", "14,111"], ["Total current assets", "153,154", "134,836"], ["Marketable securities", "138,683", "127,877"], ["Property, plant and equipment, net", "39,245", "39,440"], ["Other non-current assets", "50,109", "48,849"], ["Total non-current assets", "228,037", "216,166"], ["Total assets", "381,191", "351,002"], ["Accounts payable", "74,362", "54,763"], ["Other current liabilities", "49,167", "47,493"], ["Deferred revenue", "7,876", "7,612"], ["Commercial paper", "5,000", "6,000"], ["Term debt", "11,169", "9,613"], ["Total current liabilities", "147,574", "125,481"], ["Term debt", "106,629", "109,106"], ["Other non-current liabilities", "55,056", "53,325"], ["Total non-current liabilities", "161,685", "162,431"], ["Total liabilities", "309,259", "287,912"], ["Commitments and contingencies", "", ""], ["Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,340,851 and 16,426,786 shares issued and outstanding, respectively", "58,424", "57,365"], ["Retained earnings", "14,435", "5,562"], ["Accumulated other comprehensive income/(loss)", "(927)", "163"], ["Total shareholders\u2019 equity", "71,932", "63,090"], ["Total liabilities and shareholders\u2019 equity", "$ 381,191", "$ 351,002"]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions", "Total", "Common stock and additional paid-in capital", "Retained earnings", "Accumulated other comprehensive income/(loss)"]], "sections": ["Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]"], "data": [["Beginning balances at Sep. 26, 2020", "$ 65,339", "$ 50,779", "$ 14,966", "$ (406)"], ["Common stock withheld related to net share settlement of equity awards", "", "(1,101)", "(1,873)", ""], ["Share-based compensation", "", "2,066", "", ""], ["Net income", "28,755", "", "28,755", ""], ["Dividends and dividend equivalents declared", "", "", "(3,547)", ""], ["Common stock repurchased", "", "", "(24,000)", ""], ["Other comprehensive income/(loss)", "585", "", "", "585"], ["Ending balances at Dec. 26, 2020", "$ 66,224", "51,744", "14,301", "179"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.205", "", "", ""], ["Beginning balances at Sep. 25, 2021", "$ 63,090", "57,365", "5,562", "163"], ["Common stock withheld related to net share settlement of equity awards", "", "(1,263)", "(1,730)", ""], ["Share-based compensation", "", "2,322", "", ""], ["Net income", "34,630", "", "34,630", ""], ["Dividends and dividend equivalents declared", "", "", "(3,665)", ""], ["Common stock repurchased", "(20,400)", "", "(20,362)", ""], ["Other comprehensive income/(loss)", "(1,090)", "", "", "(1,090)"], ["Ending balances at Dec. 25, 2021", "$ 71,932", "$ 58,424", "$ 14,435", "$ (927)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.22", "", "", ""]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions", "3 Months Ended"], ["Dec. 25, 2021", "Dec. 26, 2020"]], "sections": ["Statement of Cash Flows [Abstract]", "Operating activities:", "Adjustments to reconcile net income to cash generated by operating activities:", "Changes in operating assets and liabilities:", "Investing activities:", "Financing activities:", "Supplemental cash flow disclosure:"], "data": [["Cash, cash equivalents and restricted cash, beginning balances", "$ 35,929", "$ 39,789"], ["Net income", "34,630", "28,755"], ["Depreciation and amortization", "2,697", "2,666"], ["Share-based compensation expense", "2,265", "2,020"], ["Deferred income tax expense/(benefit)", "682", "(58)"], ["Other", "167", "25"], ["Accounts receivable, net", "(3,934)", "(10,945)"], ["Inventories", "681", "(950)"], ["Vendor non-trade receivables", "(9,812)", "(10,194)"], ["Other current and non-current assets", "(4,921)", "(3,526)"], ["Accounts payable", "19,813", "21,670"], ["Deferred revenue", "462", "1,341"], ["Other current and non-current liabilities", "4,236", "7,959"], ["Cash generated by operating activities", "46,966", "38,763"], ["Purchases of marketable securities", "(34,913)", "(39,800)"], ["Proceeds from maturities of marketable securities", "11,309", "25,177"], ["Proceeds from sales of marketable securities", "10,675", "9,344"], ["Payments for acquisition of property, plant and equipment", "(2,803)", "(3,500)"], ["Other", "(374)", "195"], ["Cash used in investing activities", "(16,106)", "(8,584)"], ["Payments for taxes related to net share settlement of equity awards", "(2,888)", "(2,861)"], ["Payments for dividends and dividend equivalents", "(3,732)", "(3,613)"], ["Repurchases of common stock", "(20,478)", "(24,775)"], ["Repayments of term debt", "0", "(1,000)"], ["Proceeds from/(Repayments of) commercial paper, net", "(1,000)", "22"], ["Other", "(61)", "(22)"], ["Cash used in financing activities", "(28,159)", "(32,249)"], ["Increase/(Decrease) in cash, cash equivalents and restricted cash", "2,701", "(2,070)"], ["Cash, cash equivalents and restricted cash, ending balances", "38,630", "37,719"], ["Cash paid for income taxes, net", "5,235", "1,787"], ["Cash paid for interest", "$ 531", "$ 619"]]}]